Medical Aid in Dying Would Be Allowed

Summary#

HB 886, titled “Health care; decision-making, definitions, medical aid in dying, penalties,” would amend Virginia’s law on assisting suicide and add a new article allowing medical aid in dying under specified conditions. Its apparent goal is to let some terminally ill adults obtain a prescription for a substance they would take themselves to end their lives, with safeguards and limits.

  • An attending health care provider may take part. A provider who chooses to participate must follow the bill’s assessment, counseling, documentation, and prescription or dispensing rules.
  • To qualify, a person generally must be at least 18, a Virginia resident, have a terminal disease expected to cause death within six months, and be capable of making an informed decision. The person must make oral and written requests and have an advance directive in place before the first oral request.
  • The bill sets out safeguards, including a second oral request, a written request witnessed by an eligible person, counseling about risks and alternatives, and referral for end-of-life care. The 15-day waiting period has an exception for a patient expected to die within that period.
  • Providers may decline to participate. They must document the request and their refusal, and transfer the patient’s records to another provider upon request.
  • The bill would protect qualifying medical aid in dying from being treated as suicide or assisted suicide under law. It also sets insurance protections, allows health care entities to prohibit the practice on their premises if they follow notice rules, and creates criminal penalties for specified coercive or document-altering conduct.
  • The bill rewrites § 8.01-622.1 and adds a new article to the Code of Virginia. The prior text of § 8.01-622.1 was not supplied, so what changes in that section compared with current law could not be verified. The bill is not yet law, and it gives no general effective date.

What it means for you#

  • Adults with a terminal disease: You could request the option if you meet the eligibility rules. The bill does not require a provider to participate, and it does not guarantee that a participating provider or facility will be available to you.
  • Patients making a request: You would need an advance directive before your first oral request, make a second oral request and a written request, and be able to make and communicate an informed decision. The substance must be self-administered; lethal injection or infusion is not allowed.
  • Health care providers: A provider who participates must assess eligibility and capacity, check that the request is voluntary, explain the expected outcome and risks, discuss alternatives, document the process, and provide an appropriate end-of-life-care referral. A provider may decline.
  • Health care entities: A facility may prohibit the practice on its premises if it adopts a written policy and gives and makes available written notice. The bill does not bar a provider from doing it elsewhere, outside the provider’s work for that facility.
  • Insured people: Insurers and health plans could not deny or change benefits because the option is available, requested, or not requested. The request or use of the option also could not affect life, health, or accident insurance or annuity claims as described in the bill.
  • General public: The bill does not authorize another person to administer the life-ending substance. It makes certain coercion and tampering with a request or rescission a Class 2 felony.

Money#

The bill requires some regulatory work and could increase correctional costs, but no full cost estimate is provided.

  • The Board of Medicine must adopt rules, review a sample of provider records each year, and publish an annual statistical report. The bill gives no cost estimate or staffing amount.
  • The bill states that it may increase imprisonment or juvenile commitments. The required fiscal-impact amount for adult prison costs is at least $50,000 because the necessary appropriation cannot be determined; this is not a full estimate of actual costs.
  • A government entity may claim costs and reasonable attorney fees from a person’s estate if the person ends their life under the article in a public place.
  • No estimates are provided for provider, facility, insurance, or other compliance costs.

What is unclear#

  • The definition of “eligible patient” requires confirmation of the terminal diagnosis by a consulting provider, but the process section says confirmation is not required for a person receiving hospice care. The bill does not resolve this conflict.
  • The bill does not explain how capacity reviewers are selected, how quickly they must act, or how disputes about capacity or eligibility are handled.
  • It does not set out an appeal process, a timeline for completing the process, or a way to ensure that a willing provider is available if another provider or facility declines.
  • The bill does not specify the controlled substance or substances that may be prescribed.
  • The current text of § 8.01-622.1 and the Health Care Decisions Act were not supplied, so their existing rules and how this bill would interact with them could not be checked.

Case for#

  • The bill appears intended to give some adults facing a terminal disease a choice about the timing and manner of their death.
  • Its limits—an adult age threshold, a six-month terminal prognosis, capacity, informed consent, and repeated requests—are designed to restrict the option to people meeting stated conditions.
  • Counseling about hospice, comfort care, pain control, risks, and the expected result could help patients make an informed choice.
  • The bill protects a patient’s ability to withdraw a request and bars coercion. It also protects insurance benefits from being changed because the patient requests or does not request the option.

Case against#

  • The process concerns an irreversible outcome. The bill leaves important practical questions open, including how capacity concerns are resolved and how access works when providers or facilities decline.
  • The conflicting rules about hospice confirmation could cause uncertainty about who qualifies.
  • Requiring an advance directive before the first oral request could prevent someone from using the option if they did not already have one.
  • The bill requires annual review of only a sample of records and keeps the collected information generally from public inspection. The text does not explain how compliance problems would be found or reported beyond the annual nonidentifying statistics.